| scholarly article | Q13442814 |
| P356 | DOI | 10.3390/PH6070867 |
| P8608 | Fatcat ID | release_bwhd3gjsazg7tev7qa3l53rxcm |
| P932 | PMC publication ID | 3816705 |
| P698 | PubMed publication ID | 24276319 |
| P5875 | ResearchGate publication ID | 258922767 |
| P50 | author | Radu Silaghi-Dumitrescu | Q42776494 |
| P2093 | author name string | Augustin C Moţ | |
| Violeta-Florina Scurtu | |||
| P2860 | cites work | Genetically crosslinked hemoglobin: a structural study | Q22254746 |
| X-ray crystal structures of reduced rubrerythrin and its azide adduct: a structure-based mechanism for a non-heme diiron peroxidase | Q27639492 | ||
| A recombinant polymeric hemoglobin with conformational, functional, and physiological characteristics of an in vivo O2transporter | Q28190278 | ||
| PEGylation, successful approach to drug delivery | Q28278538 | ||
| Redox reactions of hemoglobin and myoglobin: biological and toxicological implications | Q34276285 | ||
| Oxygen carriers ("blood substitutes")--raison d'etre, chemistry, and some physiology | Q34466085 | ||
| Oxygen therapeutics: can we tame haemoglobin? | Q35712972 | ||
| Reaction of haem containing proteins and enzymes with hydroperoxides: the radical view | Q36049137 | ||
| Nature of the FeO2 bonding in myoglobin and hemoglobin: A new molecular paradigm | Q36187427 | ||
| All hemoglobin-based oxygen carriers are not created equally | Q37061124 | ||
| A leucine residue "Gates" solvent but not O2 access to the binding pocket of phascolopsis gouldii hemerythrin | Q38313626 | ||
| Mechanisms of cooperativity and allosteric regulation in proteins | Q38692121 | ||
| Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo. | Q38739381 | ||
| A mutation that improves soluble recombinant hemoglobin accumulation in Escherichia coli in heme excess | Q39480431 | ||
| Roles of hemoglobin Allostery in hypoxia-induced metabolic alterations in erythrocytes: simulation and its verification by metabolome analysis. | Q51922652 | ||
| Modulation of expression and polymerization of hemoglobin Polytaur, a potential blood substitute | Q53408180 | ||
| Artificial Oxygen Carriers: Renewed Commercial Interest and Scientific/Technological Advances | Q58134654 | ||
| ATP-hemoglobin: anomalous oxygen binding properties | Q69026194 | ||
| ATP-hemoglobin purification by ATP-agarose affinity chromatography | Q69643754 | ||
| Modification of hemoglobin--ring opened dials | Q71808254 | ||
| Liposome-induced pulmonary hypertension: properties and mechanism of a complement-mediated pseudoallergic reaction | Q74332512 | ||
| Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids | Q77292941 | ||
| Structural basis for O2 sensing by the hemerythrin-like domain of a bacterial chemotaxis protein: substrate tunnel and fluxional N terminus | Q79981989 | ||
| Hemoglobin-albumin crosslinked copolymers: reduced prooxidant reactivity | Q84219823 | ||
| Derivatization of haemoglobin with periodate-generated reticulation agents: evaluation of oxidative reactivity for potential blood substitutes | Q85229520 | ||
| Towards hemerythrin-based blood substitutes: comparative performance to hemoglobin on human leukocytes and umbilical vein endothelial cells. | Q39528482 | ||
| A new polyethyleneglycol-derivatized hemoglobin derivative with decreased oxygen affinity and limited toxicity | Q39619625 | ||
| Initiation of lipid peroxidation in biological systems | Q39665870 | ||
| Intrinsic toxicity of hemoglobin: how to counteract it. | Q40006806 | ||
| Ferryl haem protonation gates peroxidatic reactivity in globins | Q42776412 | ||
| Towards the development of hemerythrin-based blood substitutes. | Q43003847 | ||
| Structural and redox behavior of OxyVita, a zero-linked polymeric hemoglobin: comparison with natural acellular polymeric hemoglobins | Q43144997 | ||
| Hemoglobin-albumin cross-linking with disuccinimidyl suberate (DSS) and/or glutaraldehyde for blood substitutes | Q43446334 | ||
| Hemoglobin polymerized with a naturally occurring crosslinking agent as a blood substitute: in vitro and in vivo studies. | Q44993377 | ||
| Artificial cells with emphasis on cell encapsulation of genetically engineered cells | Q45890113 | ||
| Control of oxidative reactions of hemoglobin in the design of blood substitutes: role of the ascorbate-glutathione antioxidant system | Q46141365 | ||
| Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin | Q47857012 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 7 | |
| P304 | page(s) | 867-880 | |
| P577 | publication date | 2013-07-04 | |
| P1433 | published in | Pharmaceuticals | Q15750667 |
| P1476 | title | Protein-based blood substitutes: recent attempts at controlling pro-oxidant reactivity with and beyond hemoglobin | |
| P478 | volume | 6 |
| Q35995001 | Comparative In Vivo Effects of Hemoglobin-Based Oxygen Carriers (HBOC) with Varying Prooxidant and Physiological Reactivity |
| Q99578874 | Glutaraldehyde-Polymerized Hemoglobin: In Search of Improved Performance as Oxygen Carrier in Hemorrhage Models |
| Q50055459 | The Reaction of Oxy Hemoglobin with Nitrite: Mechanism, Antioxidant-Modulated Effect, and Implications for Blood Substitute Evaluation. |
Search more.